HEXPOL Valuation
Is HPOLBS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HPOLBS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HPOLBS (SEK103.4) is trading below our estimate of fair value (SEK161.35)
Significantly Below Fair Value: HPOLBS is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HPOLBS?
Other financial metrics that can be useful for relative valuation.
| What is HPOLBS's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | 10.1x |
| PEG Ratio | 2.5x |
Price to Earnings Ratio vs Peers
How does HPOLBS's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 26.1x | ||
JMAT Johnson Matthey | 24.3x | 28.4% | UK£2.6b |
CRDA Croda International | 30.9x | 16.0% | UK£5.0b |
VCT Victrex | 24.3x | 37.8% | UK£747.0m |
TET Treatt | 25x | 15.3% | UK£283.3m |
HPOLBS HEXPOL | 15.7x | 6.4% | SEK 37.4b |
Price-To-Earnings vs Peers: HPOLBS is good value based on its Price-To-Earnings Ratio (15.7x) compared to the peer average (26.1x).
Price to Earnings Ratio vs Industry
How does HPOLBS's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Earnings vs Industry: HPOLBS is good value based on its Price-To-Earnings Ratio (15.7x) compared to the European Chemicals industry average (17.8x).
Price to Earnings Ratio vs Fair Ratio
What is HPOLBS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 15.7x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HPOLBS's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | SEK 128.17 0% | 7.7% | SEK 145.00 | SEK 114.00 | n/a | 6 |
| Nov ’25 | SEK 103.40 | SEK 128.00 +23.8% | 7.8% | SEK 145.00 | SEK 114.00 | n/a | 6 |
| Oct ’25 | n/a | SEK 134.60 0% | 7.7% | SEK 147.00 | SEK 119.00 | n/a | 5 |
| Sep ’25 | n/a | SEK 136.33 0% | 7.5% | SEK 147.00 | SEK 119.00 | n/a | 6 |
| Aug ’25 | SEK 118.20 | SEK 138.00 +16.8% | 5.6% | SEK 147.00 | SEK 129.00 | n/a | 6 |
| Jul ’25 | n/a | SEK 140.50 0% | 5.5% | SEK 150.00 | SEK 129.00 | n/a | 6 |
| Jun ’25 | n/a | SEK 140.17 0% | 5.8% | SEK 150.00 | SEK 129.00 | n/a | 6 |
| May ’25 | SEK 128.30 | SEK 136.67 +6.5% | 10.5% | SEK 150.00 | SEK 108.00 | n/a | 6 |
| Apr ’25 | n/a | SEK 132.17 0% | 9.7% | SEK 147.00 | SEK 108.00 | n/a | 6 |
| Mar ’25 | n/a | SEK 132.17 0% | 9.7% | SEK 147.00 | SEK 108.00 | n/a | 6 |
| Feb ’25 | n/a | SEK 132.17 0% | 9.7% | SEK 147.00 | SEK 108.00 | n/a | 6 |
| Jan ’25 | n/a | SEK 122.00 0% | 6.6% | SEK 130.00 | SEK 108.00 | n/a | 5 |
| Dec ’24 | n/a | SEK 120.60 0% | 6.7% | SEK 130.00 | SEK 106.00 | n/a | 5 |
| Nov ’24 | n/a | SEK 120.60 0% | 6.7% | SEK 130.00 | SEK 106.00 | SEK 103.40 | 5 |
| Oct ’24 | n/a | SEK 122.80 0% | 7.8% | SEK 135.00 | SEK 107.00 | n/a | 5 |
| Sep ’24 | n/a | SEK 122.80 0% | 7.8% | SEK 135.00 | SEK 107.00 | n/a | 5 |
| Aug ’24 | n/a | SEK 122.80 0% | 7.8% | SEK 135.00 | SEK 107.00 | SEK 118.20 | 5 |
| Jul ’24 | SEK 114.10 | SEK 126.20 +10.6% | 8.7% | SEK 143.00 | SEK 110.00 | n/a | 5 |
| Jun ’24 | SEK 111.70 | SEK 126.20 +13.0% | 8.7% | SEK 143.00 | SEK 110.00 | n/a | 5 |
| May ’24 | SEK 120.20 | SEK 124.00 +3.2% | 9.3% | SEK 143.00 | SEK 110.00 | SEK 128.30 | 5 |
| Apr ’24 | SEK 128.80 | SEK 123.40 -4.2% | 8.5% | SEK 140.00 | SEK 110.00 | n/a | 5 |
| Mar ’24 | SEK 116.80 | SEK 116.75 -0.04% | 3.5% | SEK 120.00 | SEK 110.00 | n/a | 4 |
| Feb ’24 | SEK 112.20 | SEK 116.75 +4.1% | 3.5% | SEK 120.00 | SEK 110.00 | n/a | 4 |
| Jan ’24 | SEK 113.00 | SEK 124.25 +10.0% | 9.7% | SEK 142.00 | SEK 110.00 | n/a | 4 |
| Dec ’23 | SEK 113.30 | SEK 122.25 +7.9% | 9.8% | SEK 142.00 | SEK 110.00 | n/a | 4 |
| Nov ’23 | SEK 106.90 | SEK 121.75 +13.9% | 10.3% | SEK 142.00 | SEK 108.00 | n/a | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.